These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 33666884)
1. Illuminating the in vitro effects of Epstein-Barr virus and vitamin D on immune response in multiple sclerosis patients. Teymoori-Rad M; Sahraian MA; Mokhtariazad T; Nejati A; Mozdabadi RSK; Amiri MM; Shokri F; Marashi SM J Neurovirol; 2021 Apr; 27(2):260-271. PubMed ID: 33666884 [TBL] [Abstract][Full Text] [Related]
2. EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature. Nejati A; Shoja Z; Shahmahmoodi S; Tafakhori A; Mollaei-Kandelous Y; Rezaei F; Hamid KM; Mirshafiey A; Doosti R; Sahraian MA; Mahmoudi M; Shokri F; Emery V; Marashi SM Med Microbiol Immunol; 2016 Apr; 205(2):143-54. PubMed ID: 26365612 [TBL] [Abstract][Full Text] [Related]
3. The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients. Najafipoor A; Roghanian R; Zarkesh-Esfahani SH; Bouzari M; Etemadifar M Cell Immunol; 2015 Mar; 294(1):9-12. PubMed ID: 25666504 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples. Salzer J; Nyström M; Hallmans G; Stenlund H; Wadell G; Sundström P Mult Scler; 2013 Oct; 19(12):1587-91. PubMed ID: 23549431 [TBL] [Abstract][Full Text] [Related]
5. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D, Epstein-Barr virus, and endogenous retroviruses in multiple sclerosis - facts and hypotheses. Brütting C; Stangl GI; Staege MS J Integr Neurosci; 2021 Mar; 20(1):233-238. PubMed ID: 33834708 [TBL] [Abstract][Full Text] [Related]
7. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621 [TBL] [Abstract][Full Text] [Related]
8. Study of the possible link of 25-hydroxyvitamin D with Epstein-Barr virus and human herpesvirus 6 in patients with multiple sclerosis. Pérez-Pérez S; Domínguez-Mozo MI; García-Martínez MÁ; Aladro Y; Martínez-Ginés M; García-Domínguez JM; López de Silanes C; Casanova I; Ortega-Madueño I; López-Lozano L; Torrejón MJ; Arroyo R; Álvarez-Lafuente R Eur J Neurol; 2018 Dec; 25(12):1446-1453. PubMed ID: 29996002 [TBL] [Abstract][Full Text] [Related]
9. Hypovitaminosis-D and EBV: no interdependence between two MS risk factors in a healthy young UK autumn cohort. Ramien C; Pachnio A; Sisay S; Begum J; Leese A; Disanto G; Kuhle J; Giovannoni G; Rickinson A; Ramagopalan SV; Moss P; Meier UC Mult Scler; 2014 May; 20(6):751-3. PubMed ID: 24192216 [TBL] [Abstract][Full Text] [Related]
10. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. Lünemann JD; Jelcić I; Roberts S; Lutterotti A; Tackenberg B; Martin R; Münz C J Exp Med; 2008 Aug; 205(8):1763-73. PubMed ID: 18663124 [TBL] [Abstract][Full Text] [Related]
11. Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes. Pender MP; Csurhes PA; Pfluger CM; Burrows SR BMC Neurol; 2011 Aug; 11():95. PubMed ID: 21810280 [TBL] [Abstract][Full Text] [Related]
12. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321 [TBL] [Abstract][Full Text] [Related]
13. Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis. Wagner HJ; Munger KL; Ascherio A Eur J Neurol; 2004 Dec; 11(12):833-4. PubMed ID: 15667414 [TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes. Farina A; Peruzzi G; Lacconi V; Lenna S; Quarta S; Rosato E; Vestri AR; York M; Dreyfus DH; Faggioni A; Morrone S; Trojanowska M; Farina GA Arthritis Res Ther; 2017 Feb; 19(1):39. PubMed ID: 28245863 [TBL] [Abstract][Full Text] [Related]
15. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma. Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317 [TBL] [Abstract][Full Text] [Related]
16. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination. Lucas RM; Ponsonby AL; Dear K; Valery P; Pender MP; Burrows JM; Burrows SR; Chapman C; Coulthard A; Dwyer DE; Dwyer T; Kilpatrick T; Lay ML; McMichael AJ; Taylor BV; van der Mei IA; Williams D Neurology; 2011 Jul; 77(4):371-9. PubMed ID: 21753179 [TBL] [Abstract][Full Text] [Related]
18. The role of human endogenous retroviruses (HERVs) in Multiple Sclerosis and the plausible interplay between HERVs, Epstein-Barr virus infection, and vitamin D. Latifi T; Zebardast A; Marashi SM Mult Scler Relat Disord; 2022 Jan; 57():103318. PubMed ID: 35158423 [TBL] [Abstract][Full Text] [Related]